Literature DB >> 21268796

FDA approves the first oral drug for reducing multiple sclerosis relapses.

.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21268796

Source DB:  PubMed          Journal:  Harv Womens Health Watch        ISSN： 1070-910X


× No keyword cloud information.
  1 in total

1.  Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats.

Authors:  Zhiliang Xie; Min Chen; Swagata Goswami; Rajes Mani; Dasheng Wang; Samuel K Kulp; Chris C Coss; Larry J Schaaf; Fengyu Cui; John C Byrd; Ryan N Jennings; Karsten K Schober; Carrie Freed; Stephanie Lewis; Raphael Malbrue; Natarajan Muthusamy; Chad Bennett; William C Kisseberth; Mitch A Phelps
Journal:  AAPS J       Date:  2020-07-16       Impact factor: 4.009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.